Novel KRAS G12C agent with improved potency & PK properties available

  • Michael from ShamRock Pharmaceuticals
  • From United States
  • Responsive
  • Innovative Products and Technologies

Summary of the technology

Agent being offered has almost 5x greater binding and 2.6x higher potency than AMG510. Additional data available upon sincere requests. Please contact me with serious interest only.

Desired business relationship

Technology selling

Please contact me for more details and a non-confidential pitch deck. This is one of the hottest areas for oncology and targeting mutations that until recently had not been druggable. This agent has great potency and potential than the lead candidates in human testing currently.

I am serving as an agent to facilitate a deal with a US company that has the resources to develop this asset further.

Current development status

Experimental technologies

Agent has laboratory data and is ready for further testing.

More details available for serious inquiries.

Related Keywords

  • Biological Sciences
  • Biology / Biotechnology
  • Oncology
  • kras
  • targeted agents

About ShamRock Pharmaceuticals

My company is seeking to re-develop a promising anti-inflammatory that could be a blockbuster in multiple therapeutic areas.

Michael Locker

Never miss an update from Michael Locker

Create your free account to connect with Michael Locker and thousands of other innovative organizations and professionals worldwide


Send a request for information
to Michael

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.


Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support